miR-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer
PUBLISHED: 2016-04-13  723 total views, 4 today

Lili Jiang1,2Liang Yu3Xin Zhang2Fangyong Lei2Lan Wang4Xiangxia Liu5Shu Wu2Jinrong Zhu6Geyan Wu6Lixue Cao6Aibin Liu6Libing Song2,*, and Jun Li6,*

Author Affiliations

1Department of Pathophysiology, Guangzhou Medical University, Guangzhou, Guangdong, China.
2State Key Laboratory of Oncology in Southern China, Department of Experimental Research, Cancer Centre, Sun Yat-sen University, Guangzhou, Guangdong, China.
3Department of Vascular and Breast Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
4Department of Pathogen Biology and Immunology, School of Basic Courses, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
5Department of Plastic Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
6Program of Cancer Research, Affiliated Guangzhou Women and Children's Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China.

*Corresponding Authors:
Libing Song, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou 510060, China. Phone: 86-20-87343187; Fax: 86-20-87335828; E-mail:songlb@sysucc.org.cn; or Jun Li, lijun37@mail.sysu.edu.cn

L. Jiang and L. Yu contributed equally to this article.

Abstract

The strength and duration of NF-κB signaling is tightly controlled at multiple levels under physiologic conditions, but the mechanism underlying constitutive activation of the NF-κB pathway in cancer remains unclear. In this study, we investigated miRNA-mediated regulation of the NF-κB cascade in breast cancer. We report that miR-892b expression was significantly downregulated in human breast cancer specimens and correlated with poor patient survival. Overexpression of miR-892b in breast cancer cells significantly decreased tumor growth, metastatic capacity, and the ability to induce angiogenesis, whereas miR-892b depletion enhanced these properties, in vitro and in vivo. Furthermore, we demonstrate that miR-892b attenuated NF-κB signaling by directly targeting and suppressing multiple mediators of NF-κB, including TRAF2, TAK1, and TAB3, and thus, miR-892b silencing in breast cancer cells sustains NF-κB activity. Moreover, miR-892b downregulation was attributed to aberrant hypermethylation of its promoter. Taken together, our results provide insight into a new mechanism by which NF-κB signaling becomes constitutively activated in breast cancer and suggest a tumor-suppressive role for miR-829b, prompting further investigation into miRNA mimics for cancer therapy. Cancer Res; 76(5); 1101–11. ©2016 AACR.

The copyright reseverd by Cancer Res; 76(5); 1101–11. ©2016 AACR. Please log on Cancer Res to view the full text. http://cancerres.aacrjournals.org/content/76/5/1101.abstract

Author
Dr.Song Libing
+ Author Profile

Dr.Song Libing

MD, Doctorial tutor

Sun Yat-sen University Cancer Center

 

Expertise

Molecular pathogenesis and early diagnosisof malignant tumor.

 

ResearchProject

The biological mechanismsand function of oncogene- Bmi-1in breast cancer development.

Derivationof Nasopharyngeal (stem) cells and the etiology and pathology of NPC development.

Earlydiagnostic marker and target site of nasopharyngeal carcinoma, breast cancer, andesophageal cancer.

The molecular mechanisms of oncogene-AEG-1 ininducing tumor metastasis 

Email:songlb@sysucc.org.cn

Copyright © 1998 - 2017 Chinese Society of Clinical Oncology(CSCO). All Rights Reserved

京公网安备 11010502031031号

Contact Us

EMAIL:office@csco.org.cn

international@csco.org.cn

Phone:86(10)67726451 (Beijing)

86(25)84547290 (Nanjing)